We are live on ! Find out more
JUNO

Juno Therapeutics, Inc.
JUNO

Delisted

JUNO was delisted on the 5th of March, 2018.

Back to rankings

157 hedge funds and large institutions have $1.55B invested in Juno Therapeutics, Inc. in 2017 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 52 increasing their positions, 48 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

22% more capital invested

Capital invested by funds: $1.27B → $1.55B (+$281M)

12% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 26

8% more repeat investments, than reductions

Existing positions increased: 52 | Existing positions reduced: 48

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

1% less funds holding

Funds holding: 159 → 157 (-2)

26% less call options, than puts

Call options by funds: $13.1M | Put options by funds: $17.7M

Holders
157
Holders Change
-2
Holders Change %
-1.26%
% of All Funds
3.91%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
29
Increased
52
Reduced
48
Closed
26
Calls
$13.1M
Puts
$17.7M
Net Calls
-$4.61M
Net Calls Change
+$3.68M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$89.5M
2
Norges Bank
Norges Bank
Norway
+$17.9M
3
ACH
ArrowMark Colorado Holdings
Colorado
+$15.9M
4
Goldman Sachs
Goldman Sachs
New York
+$15.3M
5
CAM
Cormorant Asset Management
Massachusetts
+$13.9M

Top Sellers

Rank Fund Capital Flow
1
SCM
Scopia Capital Management
New York
-$33.5M
2
State Street
State Street
Massachusetts
-$8.62M
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$4.42M
4
AQR Capital Management
AQR Capital Management
Connecticut
-$3.76M
5
Citigroup
Citigroup
New York
-$3.64M
Name Holding Trade Value Shares
Change 		Change in
Stake
AllianceBernstein
76
AllianceBernstein
Tennessee
$792K -$3.22K -150 -0.4%
TD Asset Management
77
TD Asset Management
Ontario, Canada
$743K -$36.5K -1,700 -5%
PA
78
Profund Advisors
Maryland
$690K -$55.5K -2,586 -8%
EWM
79
Evercore Wealth Management
New York
$667K +$172K +8,000 +36%
UBS AM
80
UBS AM
Illinois
$663K +$278K +12,947 +76%
Baird Financial Group
81
Baird Financial Group
Wisconsin
$634K +$125K +5,839 +26%
BNP Paribas Financial Markets
82
BNP Paribas Financial Markets
France
$632K +$175K +8,150 +40%
Millennium Management
83
Millennium Management
New York
$617K +$597K +27,827 New
SG Americas Securities
84
SG Americas Securities
New York
$592K -$1.09M -51,027 -66%
Ohio Public Employees Retirement System (OPERS)
85
Ohio Public Employees Retirement System (OPERS)
Ohio
$580K – – –
Legal & General Group
86
Legal & General Group
United Kingdom
$574K +$382K +17,792 +221%
AG
87
Aperio Group
California
$562K +$246K +11,486 +83%
VOYA Investment Management
88
VOYA Investment Management
Georgia
$557K -$24.8K -1,157 -4%
Commonwealth Equity Services
89
Commonwealth Equity Services
Massachusetts
$490K +$10.7K +500 +2%
B
90
Bailard
California
$484K +$468K +21,800 New
FBC
91
Fairfield, Bush & Co
Connecticut
$477K +$212K +9,900 +86%
SSA
92
Schonfeld Strategic Advisors
New York
$452K +$437K +20,376 New
Federated Hermes
93
Federated Hermes
Pennsylvania
$418K -$547K -25,491 -57%
OPPM
94
Opus Point Partners Management
New York
$400K +$141K +6,552 +57%
D.E. Shaw & Co
95
D.E. Shaw & Co
New York
$395K +$382K +17,796 New
LCM
96
Laurion Capital Management
New York
$390K +$377K +17,581 New
HSBC Holdings
97
HSBC Holdings
United Kingdom
$385K -$75.9K -3,540 -17%
Bank of Montreal
98
Bank of Montreal
Ontario, Canada
$381K +$212K +9,884 +136%
M&T Bank
99
M&T Bank
New York
$381K +$369K +17,186 New
VEA
100
Virtus ETF Advisers
New York
$347K +$32.2K +1,501 +11%
2 3
4
5 6

JUNO Hedge Fund Activity: Q1 2017 in Review

157 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in Juno Therapeutics, Inc. (JUNO) for Q1 2017, worth a combined $1.55B — up 22% from $1.27B a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new JUNO positions and 26 closed out — a net gain of 3 holders — while 52 added to existing stakes and 48 trimmed.

The largest buyer was BlackRock, adding an estimated $89.5M. The largest seller was Scopia Capital Management, exiting entirely with an estimated $33.5M sold.

  • 157 institutional investors held Juno Therapeutics, Inc. (JUNO) as of Q1 2017, down from 159 in Q4 2016.
  • Funds reported $1.55B of Juno Therapeutics, Inc. stock for Q1 2017, up 22% quarter-over-quarter.
  • 29 funds opened new Juno Therapeutics, Inc. positions in Q1 2017 and 26 closed out, a net change of +3 holders.
  • The largest Juno Therapeutics, Inc. buyer in Q1 2017 was BlackRock, an estimated $89.5M added.
  • The largest Juno Therapeutics, Inc. seller in Q1 2017 was Scopia Capital Management, an estimated $33.5M sold.

Based on aggregated 13F filings for Q1 2017.